Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
LA JOLLA, Calif.--(BUSINESS WIRE)-- #ADC--Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals.
3 No-Brainer Stocks to Buy Right Now
06:45am, Sunday, 31'st Aug 2025
Some decisions require lengthy deliberations and extensive analysis. Others don't.
My 2 Favorite Stocks to Buy Right Now
04:51am, Sunday, 31'st Aug 2025
Thousands of stocks trade on U.S. stock exchanges. Even more trade off-the-counter.
National Advertising Division Refers Maze Therapeutics to Regulatory Authorities for Failure to Respond to Inquiry
11:31am, Wednesday, 27'th Aug 2025
Following a challenge brought by Vertex Pharmaceuticals Incorporated, BBB National Programs' National Advertising Division will refer claims made by Maze Therapeutics, Inc. to the appropriate regulato
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
10:00am, Wednesday, 27'th Aug 2025
Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Nasdaq Composite Live: All Eyes are on Nvidia Earnings this Week
09:34am, Tuesday, 26'th Aug 2025
Live Updates Live Coverage Has Ended Goldman Sachs just reiterated its buy rating on Nvidia 8:55 am Just this morning, analysts at Goldman Sachs reiterated a buy rating on Nvidia, ahead of earnings. �
This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy?
11:26am, Sunday, 24'th Aug 2025
Vertex Pharmaceuticals (VRTX -0.45%) is usually a market-beater, but it hasn't been so over the past year. The company's shares are down 18% over the trailing-12-month period due to a combination of h
2 Beaten-Down Stocks With Incredible Upside Potential
05:41am, Friday, 22'nd Aug 2025
What goes up can come down. Most investors have experienced this first-hand with stocks in their portfolio.
Vertex to Participate in Upcoming September Investor Conferences
04:00pm, Wednesday, 20'th Aug 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Susie Lisa, Senior Vice President, Investor
What's Wrong With Vertex Pharmaceuticals Stock?
04:14am, Wednesday, 20'th Aug 2025
Vertex Pharmaceuticals (VRTX 0.17%) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth oppor
Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More
09:01am, Monday, 18'th Aug 2025
This week's Undercovered Dozen spotlights 12 lesser-known stocks and ETFs, offering unique investment opportunities across gold, biotech, income, and tech sectors. B2Gold and Vertex Pharmaceuticals st
3 Fantastic Growth Stocks to Buy in August
06:42am, Sunday, 17'th Aug 2025
We're well into the home stretch of 2025. August is more than halfway over.
Is This Beaten-Down Stock a Buy on the Dip?
09:30am, Friday, 15'th Aug 2025
Even well-established drugmakers can lose significant market value overnight following a setback. That's what recently happened to Vertex Pharmaceuticals (VRTX 0.47%).
2 Growth Stocks That Are No-Brainer Buys Right Now
08:30am, Friday, 15'th Aug 2025
Over the past five years, the stock market has endured a pandemic and the economic issues that followed, along with inflationary pressures, geopolitical tensions, trade wars, and other macroeconomic c
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 13'th Aug 2025
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
